Next Article in Journal
Allogeneic Hematopoietic Cell Transplantation for Older Adults with Acute Myeloid Leukemia
Next Article in Special Issue
The Glucose-Regulated MiR-483-3p Influences Key Signaling Pathways in Cancer
Previous Article in Journal
Frequency of EBV LMP-1 Promoter and Coding Variations in Burkitt Lymphoma Samples in Africa and South America and Peripheral Blood in Uganda
Previous Article in Special Issue
The Cellular p53 Inhibitor MDM2 and the Growth Factor Receptor FLT3 as Biomarkers for Treatment Responses to the MDM2-Inhibitor Idasanutlin and the MEK1 Inhibitor Cobimetinib in Acute Myeloid Leukemia
Open AccessReview

p53 and the Viral Connection: Back into the Future

1
Department of Molecular Cell Biology, Weizmann Institute of Science, 76100 Rehovot, Israel
2
Department of Biochemistry and Molecular Genetics, Israel Institute for Biological Research, Box 19, 74100 Ness-Ziona, Israel
*
Author to whom correspondence should be addressed.
These authors contributed equally to this work.
This review is dedicated to the 25th memorial year of Prof. Yosef Aloni of the Weizmann Institute of Science, for his seminal and important pioneering research in the field of molecular biology of the SV40 virus.
Cancers 2018, 10(6), 178; https://doi.org/10.3390/cancers10060178
Received: 15 May 2018 / Revised: 31 May 2018 / Accepted: 1 June 2018 / Published: 4 June 2018
(This article belongs to the Special Issue p53 Signaling in Cancers)
The discovery of the tumor suppressor p53, through its interactions with proteins of tumor-promoting viruses, paved the way to the understanding of p53 roles in tumor virology. Over the years, accumulating data suggest that WTp53 is involved in the viral life cycle of non-tumor-promoting viruses as well. These include the influenza virus, smallpox and vaccinia viruses, the Zika virus, West Nile virus, Japanese encephalitis virus, Human Immunodeficiency Virus Type 1, Human herpes simplex virus-1, and more. Viruses have learned to manipulate WTp53 through different strategies to improve their replication and spreading in a stage-specific, bidirectional way. While some viruses require active WTp53 for efficient viral replication, others require reduction/inhibition of WTp53 activity. A better understanding of WTp53 functionality in viral life may offer new future clinical approaches, based on WTp53 manipulation, for viral infections. View Full-Text
Keywords: virus; p53; cancer; SV40; papilloma; zika; influenza; HIV-1; HSV-1; vaccinia virus; p53; cancer; SV40; papilloma; zika; influenza; HIV-1; HSV-1; vaccinia
Show Figures

Figure 1

MDPI and ACS Style

Aloni-Grinstein, R.; Charni-Natan, M.; Solomon, H.; Rotter, V. p53 and the Viral Connection: Back into the Future . Cancers 2018, 10, 178.

Show more citation formats Show less citations formats
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

1
Back to TopTop